FIELD: medicine, pharmacy. SUBSTANCE: invention proposes wound-healing suppository containing thiotriazoline-morpholinium 3-methyl-1,2,4-triazolyl-5-thioacetate as an active component and solid fat, for example, hydrogenated sunflower oil as fatty basis. Suppository mass is 2.28-2.52 g, the content of thiotriazoline is 0.18-0.22 g and fat the balance. Suppository is used for treatment of erosive-ulcerous damages of rectum and vagina mucosa and hepatitis of different etiology also. Use of suppositories with thiotriazoline enhances effectiveness and reduces treatment period due to broad spectrum of biological activity of thiotriazolene and its high biological availability. EFFECT: enhanced effectiveness and valuable medicinal properties of suppository. 2 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
WOUND-HEALING AGENT "THIOTRIAZOLINE UNGUENT" | 2001 |
|
RU2210367C2 |
PREPARATION FOR TREATING INFLAMMATORY DISEASES | 2000 |
|
RU2170101C1 |
WOUND-HEALING AND ANTIBACTERIAL AGENT | 2005 |
|
RU2317818C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES OF LOWER PART OF GENITOURINARY SYSTEM | 2010 |
|
RU2428173C1 |
EYE DROPS | 2020 |
|
RU2755480C1 |
METHOD FOR TREATMENT OF ALCOHOLIC LIVER DISEASES | 2004 |
|
RU2286785C2 |
SUPPOSITORY SHOWING ANTIINFLAMMATORY EFFECT | 1995 |
|
RU2097022C1 |
ORAL PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY GASTROINTESTINAL DISEASES | 2010 |
|
RU2445965C2 |
BIOLOGICALLY ACTIVE SUPPLEMENT "ZHENSKIE TRAVY" | 2002 |
|
RU2239448C2 |
ADHESIVE OINTMENT FOR TREATING ORAL MUCOSAL INVOLVEMENTS IN LICHEN ACUMINATUS | 2012 |
|
RU2508120C1 |
Authors
Dates
2003-11-20—Published
2001-06-18—Filed